Literature DB >> 9624114

Negative regulation of T cell antigen receptor signal transduction by hematopoietic tyrosine phosphatase (HePTP).

M Saxena1, S Williams, J Gilman, T Mustelin.   

Abstract

The hematopoietic tyrosine phosphatase (HePTP) is predominantly expressed in thymocytes and T lymphocytes and at lower levels in other hematopoietic cells. Expression of the gene is enhanced by the T cell growth factor interleukin-2, suggesting a role for HePTP in T cell proliferation or differentiation. We report that HePTP blocks T cell antigen receptor (TCR)-induced transcriptional activation of a reporter gene driven by a nuclear factor of activated T cells(NFAT)/AP-1 element taken from the interleukin-2 gene promoter. This effect was specific to HePTP and was abolished by a mutation (C270S) that impaired its phosphatase activity. Co-expression of HePTP also reduced TCR-induced activation of the mitogen-activated protein kinase Erk2 and the TCR-induced appearance of phosphorylated Erk. In contrast, HePTP did not affect the activation of the N-terminal c-Jun kinase, Jnk. Together these findings suggest that HePTP plays an active negative role in TCR signaling by dephosphorylating one or several signaling molecules between the receptor and the mitogen-activated protein kinase pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9624114     DOI: 10.1074/jbc.273.25.15340

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents.

Authors:  Juan José Muñoz; Céline Tárrega; Carmen Blanco-Aparicio; Rafael Pulido
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

Review 2.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

Review 3.  Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.

Authors:  Anthony C Bishop; Xin-Yu Zhang; Anna Mari Lone
Journal:  Methods       Date:  2007-07       Impact factor: 3.608

4.  TCR-induced downregulation of protein tyrosine phosphatase PEST augments secondary T cell responses.

Authors:  Yutaka Arimura; Torkel Vang; Lutz Tautz; Scott Williams; Tomas Mustelin
Journal:  Mol Immunol       Date:  2008-05-05       Impact factor: 4.407

Review 5.  p38 MAP kinases in the heart.

Authors:  Tomohiro Yokota; Yibin Wang
Journal:  Gene       Date:  2015-09-20       Impact factor: 3.688

6.  Hematopoietic protein tyrosine phosphatase suppresses extracellular stimulus-regulated kinase activation.

Authors:  M Gronda; S Arab; B Iafrate; H Suzuki; B W Zanke
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

7.  Docking interactions of hematopoietic tyrosine phosphatase with MAP kinases ERK2 and p38α.

Authors:  Andrea Piserchio; Dana M Francis; Dorothy Koveal; Kevin N Dalby; Rebecca Page; Wolfgang Peti; Ranajeet Ghose
Journal:  Biochemistry       Date:  2012-10-05       Impact factor: 3.162

8.  Signalling cross-talk between hepatocyte nuclear factor 4alpha and growth-hormone-activated STAT5b.

Authors:  Soo-Hee Park; Christopher A Wiwi; David J Waxman
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

9.  Structural basis of substrate recognition by hematopoietic tyrosine phosphatase.

Authors:  David A Critton; Antoni Tortajada; Geoffrey Stetson; Wolfgang Peti; Rebecca Page
Journal:  Biochemistry       Date:  2008-12-16       Impact factor: 3.162

10.  PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif.

Authors:  R Pulido; A Zúñiga; A Ullrich
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.